But Horizon Europe also includes new elements that reflect increasing attention to open science, equality, interdisciplinary research and practical applications. Here, Nature takes a look at some of the major changes.
As Horizon Europe issues its first call for grants, Nature reviews some big changes — from open science to goal-oriented ‘missions’.
FEATURE (THE CONVERSATION) — The history of humans’ use of technology has always been a history of co-evolution.
Philosophers from Rousseau to Heidegger to Carl Schmitt have argued that technology is never a neutral tool for achieving human ends. Technological innovations – from the most rudimentary to the most sophisticated – reshape people as they use these innovations to control their environment. Artificial intelligence is a new and powerful tool, and it, too, is altering humanity.
Writing – and later, the printing press – made it possible to carefully record history and easily disseminate knowledge, but it eliminated centuries-old traditions of oral storytelling. Ubiquitous digital and phone cameras have changed how people experience and perceive events. Widely available GPS systems have meant that drivers rarely get lost, but a reliance on them has also atrophied their native capacity to orient themselves.
This is a detailed summary of plasma dilution and at 58:38 the future is explained where they will publish human results from 25 people, then start a company whose first order of business will be phase 3 trials with more people and placebo and hopefully funding. It appears you can pay to have the procedure. The hopeful start is this year in may.
Irina will present her recent findings on plasma dilution, showing that age-reversing effects, such as rejuvenating tissues in mice, can be achieved by. diluting the blood plasma of old mice: Rejuvenation of three germ layers tissues by exchanging old blood plasma with saline-albumin.
Join us for Dr. Matt Kaeberlein’s presentation. He is the Founding Director of the UW Healthy Aging and Longevity Research Institute, and founder and co-Director of the Dog Aging Project and a Professor of Laboratory Medicine and Pathology at the University of Washington (UW) School of Medicine, with Adjunct appointments in Genome Sciences and Oral Health Sciences. Dr. Kaeberlein’s research interests are focused on biological mechanisms of aging in order to facilitate translational interventions that promote healthspan and improve quality of life.
“Our task is to make nature, the blind force of nature, into an instrument of universal resuscitation and to become a union of immortal beings.“ - Nikolai F. Fedorov.
We hold faith in the technologies & discoveries of humanity to END AGING and Defeat involuntary Death within our lifetime.
Working to Save Lives with Age Reversal Education.